06:23 AM EDT, 08/11/2025 (MT Newswires) -- Belite Bio ( BLTE ) reported a Q2 net loss Monday of $0.50 per diluted share, widening from a $0.31 loss a year earlier.
Analysts polled by FactSet expected a $0.41 loss.
The company said it held cash, liquidity funds, time deposits and US treasury bills of $149.2 million at June 30.